Patients with Ebstein’s disease frequently have not only one or more accessory pathways but also an increased incidence of atrial arrhythmias in conjunction with either a tricuspid regurgitation, a major dilatation of the right atrium or a possible surgical scar. The association between atrial fibrillation and a permeable accessory pathway can be particularly threatening.

Treatment of the accessory pathway is dependent on the presence of arrhythmias, their frequency, their severity and the degree of permeability of the accessory pathway. A class IC anti-arrhythmic treatment can be proposed. The cut-off limit separating low-risk patients who only require medical treatment and high-risk patients requiring ablation of the accessory pathway is difficult to define. For this patient presenting episodes of atrial fibrillation with rapid conduction via the accessory pathway leading to a precarious hemodynamic state, ablation appears indispensable. In patients with little or no symptoms, the preferred therapeutic approach is of greater debate. However, the benign or malignant nature should probably be systematically assessed.

The ablation procedure can be technically difficult with a lower success rate than for an accessory pathway in a healthy heart. Indeed,

1. as explained previously, a same patient may have multiple pathways; these accessory pathways may be long and of significant diameter;
2. the delineation between atrial myocardium and ventricular myocardium is less straightforward and the presence of abnormal, fragmented signs unrelated to the accessory pathway at the atrial level is frequently observed;
3. the right atrium is often very dilated, rendering the manipulation of catheters difficult and requiring the use of sheaths with large curvatures;
4. obtaining high temperatures is sometimes difficult;
5. the aggressiveness of the lesions must sometimes be limited, due to the description of lesions of the right coronary artery.